Evidence map›Paper›PMID 33748122›Full record

ReviewFrontiers in cell and developmental biology2021

Impact of TCM on Tumor-Infiltrating Myeloid Precursors in the Tumor Microenvironment.

Jinlong Liu, Yuchen Wang, Zhidong Qiu, Guangfu Lv, Xiaowei Huang, He Lin, Zhe Lin, Peng Qu

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. The potential of plant extracts in cell therapy.Stem cell research & therapy · 2022
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jinlong LiuDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Yuchen WangDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Zhidong QiuDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Guangfu LvDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Xiaowei HuangDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
He LinDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Zhe LinDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Peng QuCenter for Cancer Research, National Cancer Institute, Frederick, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor microenvironment (TME) is composed of tumor cells, blood/lymphatic vessels, the tumor stroma, and tumor-infiltrating myeloid precursors (TIMPs) as a sophisticated pathological system to provide the survival environment for tumor cells and facilitate tumor metastasis. In TME, TIMPs, mainly including tumor-associated macrophage (TAM), tumor-associated dendritic cells (DCs), and myeloid-derived suppressor cells (MDSCs), play important roles in repressing the antitumor activity of T cell or other immune cells. Therefore, targeting those cells would be one novel efficient method to retard cancer progression. Numerous studies have shown that traditional Chinese medicine (TCM) has made extensive research in tumor immunotherapy. In the review, we demonstrate that Chinese herbal medicine (CHM) and its components induce tumor cell apoptosis, directly inhibiting tumor growth and invasion. Further, we discuss that TCM regulates TME to promote effective antitumor immune response, downregulates the numbers and function of TAMs/MDSCs, and enhances the antigen presentation ability of mature DCs. We also review the therapeutic effects of TCM herbs and their ingredients on TIMPs in TME and systemically analyze the regulatory mechanisms of TCM on those cells to have a deeper understanding of TCM in tumor immunotherapy. Those investigations on TCM may provide novel ideas for cancer treatment.

Indexed as

cancer immunotherapyregulatory mechanismtraditional Chinese medicinetumor-infiltrating myeloid precursorstumor microenvironment

Identifiers

PMID33748122
PMCPMC7969811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.